Skip to content
Screener

Gyre Therapeutics, Inc. GYRE Q2 2025 earnings

Reported August 11, 2025 · Before market open

Revenue$26.8MMiss by $7.5M
EPS$0.02Miss by $0.01
Revenue estimate$34.3M
EPS estimate$0.03

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$28.4M
EPS estimate-$0.15

Financials

Q2 2025

Income statement

See full
Revenue$29.7M+17.9%
Gross profit$28.6M+16.9%
Operating income-$2.2M-170%
Net income-$2.0M-158%
EPS (diluted)-$0.03-400%

Balance sheet

See full
Cash & equivalents$36.5M+127%
Total debt$1.4M-28.8%
Total equity$92.0M+52.5%
Total assets$152.6M+26.2%

Cash flow

See full
Operating cash flow-$7.5M-36.1%
CapEx$335.0K-77.0%
Free cash flow-$7.8M-12.4%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$689.9M-32.4%
Enterprise value$654.8M-34.9%
P/E388×—
P/S6.6×-2.6×

Profitability

See full
Gross margin96%-0.2pp
Operating margin4.7%+2.4pp
Net margin1.7%+0.9pp

Returns & leverage

See full
Return on equity2.3%—
Debt / equity0×0.0×
Current ratio5.4×+2.0×

Segments

By product

See full
Collaborations$3.0M—
Etorel$1.6M—
Contiva$1.5M—
Other Product$158.0K—

By segment

See full
Gyre Pharmaceuticals$26.8M+6.1%
Gyre$3.0M—

FAQ

When did Gyre Therapeutics, Inc. report Q2 2025 earnings?
Gyre Therapeutics, Inc. (GYRE) reported Q2 2025 earnings on August 11, 2025 before market open.
What were Gyre Therapeutics, Inc.'s Q2 2025 revenue and EPS?
Gyre Therapeutics, Inc. reported revenue of $26.8M and eps of $0.02 for Q2 2025.
Did Gyre Therapeutics, Inc. beat estimates in Q2 2025?
Revenue missed the consensus estimate of $34.3M by $7.5M. EPS missed the consensus estimate of $0.03 by $0.01.
How did Gyre Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.1% from $25.2M a year earlier and eps grew 100.0% from $0.01.
Where can I find Gyre Therapeutics, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-106525) and the 10-Q periodic report (0000950170-25-106644) directly on SEC EDGAR. The filing index links above go to sec.gov.